毒性薬物スクリーニングの世界市場レポート2025年

毒性薬物スクリーニング市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.4％で306億7,000万米ドルに成長します。この将来的な成長の要因としては、個別化医療アプローチの急増、医薬品の安全性に対する規制の重点化、大麻や合成物質の使用量の増加、発展途上国における広範なヘルスケアインフラの整備、薬物乱用の蔓延などが挙げられます。この期間に予測される主な動向には、ハイスループットスクリーニングツールの革新、毒物学分析における人工知能の利用強化、ポイントオブケア毒物学診断の出現、バイオマーカー主導型スクリーニング技術の進歩、薬物スクリーニングワークフローにおける自動化およびロボットシステムの改善が含まれます。

薬物乱用の増加は、毒性薬物スクリーニング市場の成長を促進すると予想されます。薬物乱用とは、医療以外の目的で薬物を有害または過剰に摂取することを指し、個人の健康や幸福に悪影響を及ぼします。薬物乱用の増加は、ストレスや精神衛生上の問題の増大が原因であり、多くの人が対処法として薬物を使用するようになっています。毒性薬物スクリーニングは、体内の薬物やその代謝物の存在を検出し、薬物乱用や過剰摂取の早期発見、診断、監視を容易にするという重要な役割を担っています。例えば、2024年8月、スコットランドの政府機関であるスコットランド国立記録（NRS）は、2023年の薬物誤用による死亡者数を1,172人と報告しました。その結果、薬物乱用の増加率が毒性薬物スクリーニング市場の拡大に寄与しています。

毒性薬物スクリーニング市場の主要企業は、臨床、法医学、職場環境における物質検出の精度と速度を向上させるため、法毒物学スクリーニングなどの革新的ソリューションを導入しています。法医学毒物学スクリーニングは、犯罪捜査、事故、死亡事故に関連する薬物、毒物、毒素を特定するための生物学的サンプルの検査を含みます。例えば、2022年6月、米国のバイオテクノロジーおよびライフサイエンス企業であるサーモフィッシャーサイエンティフィック社は、臨床および法医学毒物学アプリケーション用に設計された包括的なLC-MS（液体クロマトグラフィー質量分析）システムであるToxSpec Analyzerを発売しました。このソリューションは、ハードウェア、ソフトウェア、および検証済みのメソッドを組み合わせて薬物分析物スクリーニングを自動化および最適化するもので、LC-MS/MSの経験が浅いラボでもこの技術を利用できます。ToxSpec Analyzerは作業効率を高め、同定精度を向上させ、ラボが必要に応じて新しい化合物を追加できるようにします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の毒性薬物スクリーニング：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の毒性薬物スクリーニング市場：成長率分析
• 世界の毒性薬物スクリーニング市場の実績：規模と成長, 2019-2024
• 世界の毒性薬物スクリーニング市場の予測：規模と成長, 2024-2029, 2034F
• 世界の毒性薬物スクリーニング：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の毒性薬物スクリーニング市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 監視とログ記録
• セキュリティ
• ストレージと継続的インテグレーションまたは継続的デプロイメント
• 管理とオーケストレーション
• ネットワークおよびデータ管理サービス
• その他のタイプ
• 世界の毒性薬物スクリーニング市場：検査タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性全身毒性
• 経皮毒性
• 発がん性
• 眼毒性
• 遺伝毒性
• 神経毒性
• 臓器特異的毒性
• 世界の毒性薬物スクリーニング市場：技術タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハイスループットスクリーニング
• ゲノミクス
• トランスクリプトミクス
• 毒性ゲノミクス
• 分子スクリーニング
• 世界の毒性薬物スクリーニング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫毒性
• 全身毒性
• 発達および生殖毒性（DART）
• 内分泌かく乱
• その他の用途
• 世界の毒性薬物スクリーニング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 契約調査機関（CRO）
• 製薬会社
• 職場検査施設
• 世界の毒性薬物スクリーニング市場、監視とログ記録、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• リアルタイム薬物モニタリングシステム
• 生体分析機器ログ
• 毒性警告通知システム
• コンプライアンスと監査証跡の監視
• 世界の毒性薬物スクリーニング市場、セキュリティ、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ラボレポート向けのデータ暗号化ソリューション
• 毒物学データのためのアクセス制御システム
• 安全なサンプル追跡システム
• HIPAAまたはGDPR準拠の薬物検査プラットフォーム
• 世界の毒性薬物スクリーニング市場、ストレージと継続的インテグレーションまたは継続的デプロイメント、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• クラウドベースのサンプルデータストレージソリューション
• 自動化された毒性レポート生成パイプライン
• LIMS（ラボ情報管理システム）統合ツール
• テストプロトコルとデータベースのバージョン管理
• 世界の毒性薬物スクリーニング市場、管理とオーケストレーション、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 毒物学研究室向けワークフロー自動化ツール
• 薬物スクリーニング管理のための集中ダッシュボード
• マルチサイトテストスケジューリングおよび調整プラットフォーム
• 実験用品のベンダー管理システム
• 世界の毒性薬物スクリーニング市場、ネットワーキングおよびデータ管理サービス、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ヘルスケアデータ交換のための相互運用性プラットフォーム
• EHR/EMRシステムによる毒物学データ統合サービス
• 毒性試験結果と分析のためのリモートアクセス
• 毒物学およびスクリーニング記録のデータウェアハウス
• 世界の毒性薬物スクリーニング市場、その他のタイプ、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• AIを活用した予測毒性学プラットフォーム
• モバイル薬物スクリーニングアプリケーション
• ブロックチェーンベースのChain of Custodyソリューション
• 毒物学ワークフローにおける音声・画像認識ツール

第7章 地域別・国別分析

• 世界の毒性薬物スクリーニング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の毒性薬物スクリーニング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 毒性薬物スクリーニング市場：競合情勢
• 毒性薬物スクリーニング市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• BD Bioscience
• Quest Diagnostics
• ICON plc
• Agilent Technologies Inc.
• Eurofins Scientific SE
• Wuxi AppTec
• Charles River Laboratories International Inc.
• Shimadzu Corporation
• Waters Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Evotec AG
• Promega Corporation
• The Jackson Laboratory
• Clinical Reference Laboratory Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 毒性薬物スクリーニング市場2029：新たな機会を提供する国
• 毒性薬物スクリーニング市場2029：新たな機会を提供するセグメント
• 毒性薬物スクリーニング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Toxicology drug screening is a process designed to detect drugs, chemicals, or their metabolites in biological samples such as urine, blood, saliva, or hair. This type of medical testing is frequently utilized to identify both legal and illegal substances present in a person's system. Its primary purpose is to determine and assess drug exposure in an individual, serving a variety of needs depending on the application context.

Toxicology drug screening encompasses several major types, including monitoring and logging, security, storage, continuous integration or deployment, management and orchestration, networking, data management services, and others. Monitoring and logging refer to the ongoing tracking and documentation of data derived from tests and related activities. This category involves multiple test types such as acute systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity. It also incorporates advanced technologies like high-throughput screening, genomics, transcriptomics, toxicogenomics, and molecular screening. Applications include immunotoxicity, systemic toxicity, developmental and reproductive toxicity (DART), endocrine disruption, among others. The end users of these screenings span across hospitals, clinics, contract research organizations (CROs), pharmaceutical firms, and workplace drug testing centers.

The toxicology drug screening market research report is one of a series of new reports from The Business Research Company that provides toxicology drug screening market statistics, including toxicology drug screening industry global market size, regional shares, competitors with a toxicology drug screening market share, detailed toxicology drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the toxicology drug screening industry. This toxicology drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The toxicology drug screening market size has grown strongly in recent years. It will grow from $19.56 billion in 2024 to $21.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The historical growth is driven by increasing instances of drug misuse, the introduction of workplace drug testing regulations, a rise in toxicology testing in athletic settings, the expansion of forensic toxicology capabilities, and the growing use of toxicology analysis in criminal investigations.

The toxicology drug screening market size is expected to see strong growth in the next few years. It will grow to $30.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. Contributing factors to this future growth include the surge in personalized medicine approaches, heightened regulatory emphasis on drug safety, an uptick in the usage of cannabis and synthetic substances, broader healthcare infrastructure development in developing countries, and the increasing prevalence of substance abuse. Key trends projected during this period involve innovations in high-throughput screening tools, enhanced use of artificial intelligence in toxicology analytics, the emergence of point-of-care toxicology diagnostics, progress in biomarker-driven screening techniques, and improved automation and robotic systems in drug screening workflows.

The increasing prevalence of drug abuse is anticipated to drive the growth of the toxicology drug screening market. Drug abuse refers to the harmful or excessive consumption of drugs for non-medical purposes, which adversely affects an individual's health and well-being. The rise in drug abuse is attributed to growing stress and mental health issues, prompting many to use substances as a coping mechanism. Toxicology drug screening plays a crucial role in detecting the presence of drugs or their metabolites in the body, facilitating early identification, diagnosis, and monitoring of substance misuse or overdose. For example, in August 2024, the National Records of Scotland (NRS), a government department in Scotland, reported 1,172 drug misuse deaths in 2023, reflecting a 12% increase (121 additional deaths) compared to 2022. As a result, the rising incidence of drug abuse is contributing to the expansion of the toxicology drug screening market.

Leading companies in the toxicology drug screening market are introducing innovative solutions such as forensic toxicology screening to improve the accuracy and speed of substance detection in clinical, forensic, and workplace environments. Forensic toxicology screening involves the examination of biological samples to identify drugs, poisons, or toxins associated with criminal investigations, accidents, or fatalities. For instance, in June 2022, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences firm, launched the ToxSpec Analyzer, a comprehensive LC-MS (liquid chromatography-mass spectrometry) system designed for clinical and forensic toxicology applications. This solution combines hardware, software, and validated methods to automate and optimize drug analyte screening, making the technology accessible even to labs with limited experience in LC-MS/MS. The ToxSpec Analyzer enhances operational efficiency, boosts identification accuracy, and allows laboratories to add new compounds as needed.

In September 2024, Scantox Group, a preclinical contract research organization based in Denmark that specializes in toxicology testing, acquired Gentronix for an undisclosed sum. The acquisition is intended to strengthen Scantox Group's early toxicity testing capabilities by incorporating Gentronix's expertise in genetic toxicology and predictive safety evaluation, thereby broadening its services for the pharmaceutical and chemical sectors. Gentronix, headquartered in the UK, is a preclinical contract research organization offering toxicology services, including drug screening.

Major players in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, and Alere Inc.

North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in toxicology drug screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the toxicology drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The toxicology drug screening market consists of revenues earned by entities by providing services, such as pre-employment drug testing, sports drug testing, confirmatory testing, addiction treatment monitoring, and pain management monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Toxicology Drug Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on toxicology drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for toxicology drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The toxicology drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Monitoring And Logging; Security; Storage And Continuous Integration Or Continuous Deployment; Management And Orchestration; Networking And Data Management Services; Other Types
• 2) By Test Type: Acute Systemic Toxicity; Dermal Toxicity; Carcinogenicity; Ocular Toxicity; Genotoxicity; Neurotoxicity; Organ-Specific Toxicity
• 3) By Technology Type: High-Throughput Screening; Genomics; Transcriptomics; Toxicogenomics; Molecular Screening
• 4) By Application: Immunotoxicity; Systemictoxicity; Developmental And Reproductive Toxicity (DART); Endocrine Disruption; Other Applications
• 5) By End Users: Hospitals; Clinics; Contract Research Organizations (CROs); Pharmaceutical Companies; Workplace Testing Facilities
• Subsegments:
• 1) By Monitoring And Logging: Real-Time Drug Monitoring Systems; Bioanalytical Instrumentation Logs; Toxicity Alert Notification Systems; Compliance And Audit Trail Monitoring
• 2) By Security: Data Encryption Solutions For Lab Reports; Access Control Systems For Toxicology Data; Secure Sample Tracking Systems; HIPAA Or GDPR-Compliant Drug Testing Platforms
• 3) By Storage And Continuous Integration Or Continuous Deployment: Cloud-Based Sample Data Storage Solutions; Automated Toxicology Report Generation Pipelines; LIMS (Laboratory Information Management Systems) Integration Tools; Version Control For Test Protocols And Databases
• 4) By Management And Orchestration: Workflow Automation Tools For Toxicology Labs; Centralized Dashboard For Drug Screening Management; Multi-Site Test Scheduling And Coordination Platforms; Vendor Management Systems For Lab Supplies
• 5) By Networking And Data Management Services: Interoperability Platforms For Healthcare Data Exchange; Toxicology Data Integration Services With EHR/EMR Systems; Remote Access For Toxicology Results And Analysis; Data Warehousing For Toxicology And Screening Records
• 6) By Other Types: AI-Powered Predictive Toxicology Platforms; Mobile Drug Screening Applications; Blockchain-Based Chain Of Custody Solutions; Voice And Image Recognition Tools In Toxicology
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Merck KGaA; Siemens Healthineers
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Toxicology Drug Screening Market Characteristics

3. Toxicology Drug Screening Market Trends And Strategies

4. Toxicology Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Toxicology Drug Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Toxicology Drug Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Toxicology Drug Screening Market Growth Rate Analysis
• 5.4. Global Toxicology Drug Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Toxicology Drug Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Toxicology Drug Screening Total Addressable Market (TAM)

6. Toxicology Drug Screening Market Segmentation

• 6.1. Global Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monitoring And Logging
• Security
• Storage And Continuous Integration Or Continuous Deployment
• Management And Orchestration
• Networking And Data Management Services
• Other Types
• 6.2. Global Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Systemic Toxicity
• Dermal Toxicity
• Carcinogenicity
• Ocular Toxicity
• Genotoxicity
• Neurotoxicity
• Organ-Specific Toxicity
• 6.3. Global Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Throughput Screening
• Genomics
• Transcriptomics
• Toxicogenomics
• Molecular Screening
• 6.4. Global Toxicology Drug Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunotoxicity
• Systemictoxicity
• Developmental And Reproductive Toxicity (DART)
• Endocrine Disruption
• Other Applications
• 6.5. Global Toxicology Drug Screening Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Contract Research Organizations (CROs)
• Pharmaceutical Companies
• Workplace Testing Facilities
• 6.6. Global Toxicology Drug Screening Market, Sub-Segmentation Of Monitoring And Logging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-Time Drug Monitoring Systems
• Bioanalytical Instrumentation Logs
• Toxicity Alert Notification Systems
• Compliance And Audit Trail Monitoring
• 6.7. Global Toxicology Drug Screening Market, Sub-Segmentation Of Security, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Encryption Solutions For Lab Reports
• Access Control Systems For Toxicology Data
• Secure Sample Tracking Systems
• HIPAA Or GDPR-Compliant Drug Testing Platforms
• 6.8. Global Toxicology Drug Screening Market, Sub-Segmentation Of Storage And Continuous Integration Or Continuous Deployment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based Sample Data Storage Solutions
• Automated Toxicology Report Generation Pipelines
• LIMS (Laboratory Information Management Systems) Integration Tools
• Version Control For Test Protocols And Databases
• 6.9. Global Toxicology Drug Screening Market, Sub-Segmentation Of Management And Orchestration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Workflow Automation Tools For Toxicology Labs
• Centralized Dashboard For Drug Screening Management
• Multi-Site Test Scheduling And Coordination Platforms
• Vendor Management Systems For Lab Supplies
• 6.10. Global Toxicology Drug Screening Market, Sub-Segmentation Of Networking And Data Management Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Interoperability Platforms For Healthcare Data Exchange
• Toxicology Data Integration Services With EHR/EMR Systems
• Remote Access For Toxicology Results And Analysis
• Data Warehousing For Toxicology And Screening Records
• 6.11. Global Toxicology Drug Screening Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Powered Predictive Toxicology Platforms
• Mobile Drug Screening Applications
• Blockchain-Based Chain Of Custody Solutions
• Voice And Image Recognition Tools In Toxicology Workflows

7. Toxicology Drug Screening Market Regional And Country Analysis

• 7.1. Global Toxicology Drug Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Toxicology Drug Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Toxicology Drug Screening Market

• 8.1. Asia-Pacific Toxicology Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Toxicology Drug Screening Market

• 9.1. China Toxicology Drug Screening Market Overview
• 9.2. China Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Toxicology Drug Screening Market

• 10.1. India Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Toxicology Drug Screening Market

• 11.1. Japan Toxicology Drug Screening Market Overview
• 11.2. Japan Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Toxicology Drug Screening Market

• 12.1. Australia Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Toxicology Drug Screening Market

• 13.1. Indonesia Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Toxicology Drug Screening Market

• 14.1. South Korea Toxicology Drug Screening Market Overview
• 14.2. South Korea Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Toxicology Drug Screening Market

• 15.1. Western Europe Toxicology Drug Screening Market Overview
• 15.2. Western Europe Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Toxicology Drug Screening Market

• 16.1. UK Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Toxicology Drug Screening Market

• 17.1. Germany Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Toxicology Drug Screening Market

• 18.1. France Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Toxicology Drug Screening Market

• 19.1. Italy Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Toxicology Drug Screening Market

• 20.1. Spain Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Toxicology Drug Screening Market

• 21.1. Eastern Europe Toxicology Drug Screening Market Overview
• 21.2. Eastern Europe Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Toxicology Drug Screening Market

• 22.1. Russia Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Toxicology Drug Screening Market

• 23.1. North America Toxicology Drug Screening Market Overview
• 23.2. North America Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Toxicology Drug Screening Market

• 24.1. USA Toxicology Drug Screening Market Overview
• 24.2. USA Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Toxicology Drug Screening Market

• 25.1. Canada Toxicology Drug Screening Market Overview
• 25.2. Canada Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Toxicology Drug Screening Market

• 26.1. South America Toxicology Drug Screening Market Overview
• 26.2. South America Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Toxicology Drug Screening Market

• 27.1. Brazil Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Toxicology Drug Screening Market

• 28.1. Middle East Toxicology Drug Screening Market Overview
• 28.2. Middle East Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Toxicology Drug Screening Market

• 29.1. Africa Toxicology Drug Screening Market Overview
• 29.2. Africa Toxicology Drug Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Toxicology Drug Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Toxicology Drug Screening Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Toxicology Drug Screening Market Competitive Landscape And Company Profiles

• 30.1. Toxicology Drug Screening Market Competitive Landscape
• 30.2. Toxicology Drug Screening Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Toxicology Drug Screening Market Other Major And Innovative Companies

• 31.1. BD Bioscience
• 31.2. Quest Diagnostics
• 31.3. ICON plc
• 31.4. Agilent Technologies Inc.
• 31.5. Eurofins Scientific SE
• 31.6. Wuxi AppTec
• 31.7. Charles River Laboratories International Inc.
• 31.8. Shimadzu Corporation
• 31.9. Waters Corporation
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. Bruker Corporation
• 31.12. Evotec AG
• 31.13. Promega Corporation
• 31.14. The Jackson Laboratory
• 31.15. Clinical Reference Laboratory Inc.

32. Global Toxicology Drug Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Toxicology Drug Screening Market

34. Recent Developments In The Toxicology Drug Screening Market

35. Toxicology Drug Screening Market High Potential Countries, Segments and Strategies

• 35.1 Toxicology Drug Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Toxicology Drug Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Toxicology Drug Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer